You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
微創腦科學(02172.HK):預計上半年淨溢利約4500萬元-6000萬元 同比扭虧為盈
格隆匯 07-16 19:59

格隆匯7月16日丨微創腦科學(02172.HK)公佈,於截至2023年6月30日止六個月內,預期集團錄得:(i)收入約為人民幣2.90億元至人民幣3.10億元之間,較上年同期增長約41%至51%;(ii)營業溢利約為人民幣7500萬元至人民幣9000萬元之間,較上年同期增長約452%至563%;(iii)淨溢利約為人民幣4500萬元至人民幣6000萬元之間,與上年同期相比,將實現扭虧為盈。

根據現時所得資料,董事會認為前述集團收入及盈利水平的預期增幅主要歸功於下列原因:(i)集團市場份額領先產品(包括Tubridge®血流導向密網支架等)不斷提升市場滲透率,競爭優勢進一步鞏固,保持良好增長態勢;(ii)集團近年上市的多個新產品(包括NUMEN®可解脱栓塞彈簧圈、Bridge®椎動脈雷帕黴素靶向洗脱支架系統及U-track®顱內支撐導管系統等)持續推進招標入院,助力開拓空白市場;(iii)集團2022年新獲批產品(包括Neurohawk®顱內取栓支架、Diveer®顱內球囊擴張導管等)加速市場開拓,貢獻集團收入增量。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account